Mode
Text Size
Log in / Sign up
N/A N=80 Randomized Single-blind Treatment

Clinical Evaluation of Stenfilcon A Contact Lenses

Myopia

Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Lens Movement — 0; 0; 0; 3 Number of eyes

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
stenfilcon A lens (Device); narafilcon A lens (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Apr 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Lens Movement
0; 0; 5; 11; 32; 26
PRIMARY
Lens Movement
0; 0; 5; 11; 32; 26
PRIMARY
Horizontal Lens Centration
0; 0; 1; 8; 39; 32
PRIMARY
Horizontal Lens Centration
0; 0; 1; 8; 39; 32
PRIMARY
Vertical Lens Centration
0; 0; 1; 6; 39; 28
PRIMARY
Vertical Lens Centration
0; 0; 1; 6; 39; 28
PRIMARY
Corneal Coverage
40; 40; 0; 0
PRIMARY
Corneal Coverage
40; 40; 0; 0
PRIMARY
Lens Lag
39; 36; 1; 4; 0; 0
PRIMARY
Lens Lag
39; 36; 1; 4; 0; 0
PRIMARY
Overall Fitting Performance
32; 22; 6; 14; 2; 4
PRIMARY
Overall Fitting Performance
32; 22; 6; 14; 2; 4
PRIMARY
Investigator Fit Preference
5; 12; 17; 6; 0
PRIMARY
Investigator Fit Preference
5; 12; 17; 6; 0
SECONDARY
Comfort
8.2; 8.4
SECONDARY
Comfort
8.2; 8.4
SECONDARY
Comfort
8.2; 8.4
SECONDARY
Dryness
8.5; 8.4
SECONDARY
Dryness
8.5; 8.4
SECONDARY
Dryness
8.5; 8.4
SECONDARY
Stinging/Burning
9.6; 9.6
SECONDARY
Stinging/Burning
9.6; 9.6
SECONDARY
Stinging/Burning
9.6; 9.6
SECONDARY
Edge/Lens Awareness
8.7; 9.2
SECONDARY
Edge/Lens Awareness
8.7; 9.2
SECONDARY
Edge/Lens Awareness
8.7; 9.2
SECONDARY
Subjective Lens Preference
12; 18; 1; 9
SECONDARY
Subjective Lens Preference
12; 18; 1; 9
SECONDARY
Subjective Lens Preference
12; 18; 1; 9

Summary

This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control).

Eligibility Criteria

Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  • Is Japanese
  • Has had a self-reported oculo-visual examination in the last two years.
  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Has read and understood the informed consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
  • Currently wears soft contact lenses.
  • Has clear corneas and no active ocular disease.

Exclusion Criteria

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03471832). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search